The Independent Voice of
European Private Equity

Advanced Search

Duke Street carves out generics division from DCC

Nicholas Neveling 3 June 2019

Duke Street as agreed to acquire Kent Pharmaceuticals and Athlone Laboratories, manufacturers of generic pharmaceuticals, from DCC Vital.

Duke Street said the deal was similar to its carve-out of Baywater Healthcare in the US, which it sold on in 2017.

The

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19